Jon Faiz Kayyem bought $500K of INBX stock

Jon Faiz Kayyem, Dir of Inhibrx Biosciences, Inc. (INBX), bought 5,000 shares of INBX stock worth $500K, per an SEC Form 4 filed Sep 17, 2026.

It was an open-market purchase.

The trade happened on Sep 16, 2026, 1 day before it was made public.

INBX has moved -9.9% since the trade date, from $101.77 to $91.74 (Nov 9, 2026 close).